43
Participants
Start Date
January 29, 2024
Primary Completion Date
October 25, 2024
Study Completion Date
October 25, 2024
Lab demo 1.0
During the intervention, transcutaneous spectral data are collected continuously with the Lab demo. Up to 20 whole blood glucose reference values are also collected, as well as interstitial fluid glucose values using a continuous glucose monitoring device. Some participants will attend multiple measurement sessions.
Liom Health AG, Pfaeffikon
Lead Sponsor
Liom Health AG
INDUSTRY